New Insights into the Interaction Between Cannabis and Tobacco

Recently, a new scientific study has revealed intriguing results about the interaction between cannabis and tobacco use, which may explain the underlying reasons for increased psychological symptoms in users of both substances. These findings highlight a molecular mechanism that may exacerbate these symptoms, making it more difficult for smokers to quit cannabis.

A New Molecular Mechanism in the Brain

The researchers focused on an enzyme called FAAH, which is responsible for breaking down a compound known as anandamide, affecting mood and response to psychological stress. Imaging studies showed that people who use both cannabis and tobacco had elevated levels of this enzyme compared to those who use only cannabis, leading to decreased levels of anandamide. This is associated with increased anxiety, depression, and a higher likelihood of relapse when attempting to quit cannabis.

Prevalence of Combined Cannabis and Tobacco Use

Despite a general decline in tobacco use in Canada, most cannabis users still report using tobacco as well. Previous studies often focused on the effects of each substance separately, leaving a significant gap in understanding their combined effects. The current study aims to fill this gap by providing preliminary evidence of these complex interactions.

Study Details and Observations

The study involved 13 adults, with eight using only cannabis and five using both cannabis and smoking cigarettes daily. The study did not include a comparison group of tobacco-only users, which means the results might be due to tobacco effects alone. However, the researchers believe there is a complex interaction between the two substances.

What surprised the researchers was the strength of the effect observed, which was markedly different between cannabis-only users and those using both substances.

Future Research Steps

The research team plans to conduct further studies to understand the role of tobacco in these brain changes by recruiting individuals who smoke cigarettes or use nicotine through vaping, to explore whether these changes appear in the absence of cannabis.

Conclusion

This study contributes to opening new avenues for understanding the interaction between cannabis and tobacco and their effects on mental health. Identifying the shared molecular mechanism between the two substances is an important step towards developing future treatments for cannabis use disorder, especially for those who also use tobacco. Currently, available treatments are limited to behavioral sessions, but ongoing research may pave the way for new therapeutic options.